Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Melanoma vaccines, revisited: a review, update.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2014
Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide.
Journal of surgical oncology·1997
Surgical transfer of the sartorius muscle to the groin after lymphadenectomy or debridement: CT findings.
AJR. American journal of roentgenology·1996
Breast cancer prevention trial.
Maryland medical journal (Baltimore, Md. : 1985)·1994
Survival differences between black and white women with breast cancer.
Journal of surgical oncology·1994
Adjuvant immunotherapy in melanoma: a new approach.
Journal of surgical oncology·1992
Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.
Maryland medical journal (Baltimore, Md. : 1985)·2000
Seroprevalence study of Hantavirus infection in the community based population.
Maryland medical journal (Baltimore, Md. : 1985)·2000
Pneumomediastinum: the Valsalva crunch.
Maryland medical journal (Baltimore, Md. : 1985)·2000
Hepatic hydrothorax: diagnosis and management. Case report and review of the literature.
Maryland medical journal (Baltimore, Md. : 1985)·2000
A case of post-streptococcal reactive arthritis.
Maryland medical journal (Baltimore, Md. : 1985)·2000
Sexual practices of older adults in a high HIV prevalence environment.
Maryland medical journal (Baltimore, Md. : 1985)·2000
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026